Andere Sprachen Fennec Pharmaceuticals Inc.

Aktien

A12A5F

CA31447P1009

FENC

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 24.04.2024			% 5 Tage	% 1. Jan.
9.07 ^USD	-1.84%		-6.49%	-19.16%

23.04.	Fennec Pharmaceuticals Insider verkaufte Aktien im Wert von $414.472, laut einer aktuellen SEC Einreichung	MT
19.04.	Fennec Pharmaceuticals Insider verkaufte Aktien im Wert von $433.996, laut einer aktuellen SEC Einreichung	MT

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Fennec Pharmaceuticals Insider Sold Shares Worth $414,472, According to a Recent SEC Filing	23.04.
Fennec Pharmaceuticals Insider Sold Shares Worth $433,996, According to a Recent SEC Filing	19.04.
Fennec Pharmaceuticals Insider Sold Shares Worth $457,182, According to a Recent SEC Filing	17.04.
Fennec Pharmaceuticals Insider Sold Shares Worth $958,669, According to a Recent SEC Filing	05.04.
Fennec Pharmaceuticals Insider Sold Shares Worth $437,451, According to a Recent SEC Filing	03.04.
Fennec Pharmaceuticals : Corporate Presentation March 2024	31.03.
Wedbush on Fennec's Q4	21.03.
Fennec Pharmaceuticals up 3.2% in US Premarket, Reports Narrower Q4 Loss of $0.10 Per Share	21.03.
Fennec Pharmaceuticals Brief: Cited Pro forma fourth quarter cash in excess of US$55 million	21.03.
Fennec Pharmaceuticals Brief: Achieved PEDMARK Full-Year 2023 Net Product Sales of US$21.3 Million, Including $9.7 Million in Net Product Sales in the Fourth Quarter of 2023	21.03.
North American Morning Briefing : Investors -2-	21.03.
Fennec Pharmaceuticals Brief: Net losses for the fourth quarter and year ended December 31, 2023, of US$2.7 million ($0.10 per share) and $16.0 million ($0.60 per share), respectively	21.03.
Fennec Pharmaceuticals Reports Full Year and Fourth Quarter 2023 Financial Results and Provides Business Update	21.03.
Fennec Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	21.03.
Fennec Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	21.03.
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024	19.03.
Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2023 Financial Results on March 21, 2024	19.03.
Wedbush on Fennec's Deal for Pedmarqsi in EU	18.03.
Sector Update: Health Care Stocks Steady Premarket Monday	18.03.
Sector Update: Health Care	18.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Fennec Pharmaceuticals Inc.

Aktien

A12A5F

CA31447P1009

FENC

Andere Sprachen

Filter